January 2010

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial
Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Motavizumab Study Group (Collins, MA)

For a complete reference, please click here.